Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Crit Care Med. 2010 Feb;38(2):612–618. doi: 10.1097/CCM.0b013e3181c027ae

Figure 4.

Figure 4

Effects of recombinant osteopontin (OPN) treatment on matrix metalloproteinase (MMP)-9 induction and tissue inhibitor of MMP (TIMP)-1 reduction in the left cerebral hemisphere at 24 hours after subarachnoid hemorrhage (SAH). Western blots for MMP-9 (A), TIMP-1 (B), laminin (C) and zona occludens (ZO)-1 (D). Expression levels of each protein in Western blot are expressed as a ratio of β-actin levels for normalization. N=6 rats per group; error bar, SD.